Curia Global, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 21 Corporate Cir, Albany, New York (NY) 12203, United States (USA)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 1000220178 · DUNS 080046430
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-05-09
- VAIDrug Quality Assurance2019-01-15
- VAIDrug Quality Assurance2013-12-12
- NAIDrug Quality Assurance2011-06-13
- NAIDrug Quality Assurance2010-08-18
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- dexamethasoneEyePoint Pharmaceuticals US, Inc
- RisperidoneIndivior Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.